Initiative highlights need for clearer communication across care teams
Written by Andrea Lobo | April 14, 2026
- Campaign supports earlier identification of Parkinson’s symptoms and clearer communication among care teams.
- Low symptom awareness, especially in younger people, may delay diagnosis. The campaign highlights off episodes.
- Bial is developing BIA 28-6156 for people with Parkinson’s and a GBA1 gene variation, now in a Phase 2b trial.
Bial has launched an international education campaign to support clearer communication and the early identification of symptoms among people with Parkinson’s disease, carers, and healthcare professionals.
The year-long campaign, called “Dialogues with Parkinson’s,” is being developed in collaboration with Parkinson’s Europe to mark World Parkinson’s Day, held on April 11 during Parkinson’s Awareness Month. It includes digital content and educational resources, such as guides and checklists, to help build a shared language among patients, carers, and healthcare professionals.
Company continues research into potential Parkinson’s treatment
The company is developing BIA 28-6156 for people with Parkinson’s who have a pathogenic variation in the GBA1 gene. The molecule is being evaluated in the Phase 2b ACTIVATE trial (NCT05819359). According to the company, topline results are expected by the end of the first half of this year.
Recent Comments